INVO FERTILITY INC

Invo Fertility slides 2.74 % as the 200‑day SMA stays above price—can regulatory approvals or new partnerships unlock its hidden value?

Invo Fertility’s stock drops nearly 9% amid thin liquidity, yet new IVF kit data and U.S. distributor talks hint at a potential rebound and strategic capital raise.